AURINIA PHARMACEUTICALS INC(NASDAQ:AUPH) stock News

AUPH Latest News, Press Relases and Analysis

All

Press Releases

10 days ago - By: Chartmill

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Passes Louis Navellier's Growth Screen

7 days ago - By: Stocktwits

Aurinia Pharma Stands By Lupus Drug After FDA Official’s Retracted Post Sparks 16% Selloff — Retail Stays Bullish On Recovery

7 days ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Responds to Now Retracted LinkedIn Post

7 days ago - By: Benzinga - Mentions: NBY NEOG PMI APDN ...

12 Health Care Stocks Moving In Monday's After-Market Session

7 days ago - By: Bloomberg

Aurinia Sinks After FDA Official Questions Its Drug on LinkedIn

a month ago - By: Investor's Business Daily - Mentions: UTHR HALO ARGX

United Therapeutics Price Strength Rating Jumps After Its Stock Soared 33% Last Week On Positive Drug Test Results

a month ago - By: Investor's Business Daily - Mentions: ARGX HALO RIGL

Argenx Stock Hits Record High After Reporting 664% Earnings Surge; This Rating Upgraded

2 months ago - By: Zacks Investment Research

Aurinia (AUPH) Upgraded to Buy: Here's What You Should Know

2 months ago - By: Investor's Business Daily - Mentions: GILD INCY KNSA

Gilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter?

2 months ago - By: The Motley Fool

Aurinia (AUPH) Q2 Revenue Jumps 22%

2 months ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2025

2 months ago - By: Benzinga - Mentions: BSAC BGC RMNI MTZ ...

Earnings Scheduled For July 31, 2025

3 months ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025

3 months ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)

3 months ago - By: Stocktwits

Retail Bulls Charge Into Aurinia Pharmaceuticals Ahead Of Autoimmune Trial Results

3 months ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025

4 months ago - By: Zacks Investment Research

Is the Options Market Predicting a Spike in Aurinia Pharmaceuticals (AUPH) Stock?

5 months ago - By: Aurinia Pharmaceuticals Inc.

New AURORA 1 Analysis: LUPKYNIS-Based Triple Immunosuppressive Therapy Yields Deep Proteinuria Reduction in Lupus Nephritis

5 months ago - By: Zacks Investment Research - Mentions: NRG HBM FOX

Company News for May 13, 2025

5 months ago - By: Stocktwits - Mentions: IWM IWO EXPE

Aurinia Stock Rallies On Upbeat Q1 Earnings, CEO Expects Strong Performance in 2025: Retail Sentiment Brightens

5 months ago - By: Zacks Investment Research - Mentions: DERM

Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates

5 months ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

5 months ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025

5 months ago - By: Aurinia Pharmaceuticals Inc.

Glass Lewis Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting

5 months ago - By: Aurinia Pharmaceuticals Inc.

ISS Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting

6 months ago - By: Yahoo Finance - Mentions: PEP HRTG MRX VRTX ...

Tariff turmoil: What P&G, Pepsi and other companies are saying about tariffs

6 months ago - By: Zacks Investment Research - Mentions: ESPR HRTX PSTV PYXS

AURINIA PHARMACEUTICALS INC (AUPH) Stock News

AUPH Latest News, Press Relases and Analysis

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Passes Louis Navellier's Growth Screen

Aurinia Pharma Stands By Lupus Drug After FDA Official’s Retracted Post Sparks 16% Selloff — Retail Stays Bullish On Recovery

Aurinia Responds to Now Retracted LinkedIn Post

12 Health Care Stocks Moving In Monday's After-Market Session

Aurinia Sinks After FDA Official Questions Its Drug on LinkedIn

United Therapeutics Price Strength Rating Jumps After Its Stock Soared 33% Last Week On Positive Drug Test Results

Argenx Stock Hits Record High After Reporting 664% Earnings Surge; This Rating Upgraded

Aurinia (AUPH) Upgraded to Buy: Here's What You Should Know

Gilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter?

Aurinia (AUPH) Q2 Revenue Jumps 22%

Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2025

Earnings Scheduled For July 31, 2025

Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025

Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)

Retail Bulls Charge Into Aurinia Pharmaceuticals Ahead Of Autoimmune Trial Results

Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025

Is the Options Market Predicting a Spike in Aurinia Pharmaceuticals (AUPH) Stock?

New AURORA 1 Analysis: LUPKYNIS-Based Triple Immunosuppressive Therapy Yields Deep Proteinuria Reduction in Lupus Nephritis

Company News for May 13, 2025

Aurinia Stock Rallies On Upbeat Q1 Earnings, CEO Expects Strong Performance in 2025: Retail Sentiment Brightens

Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates

Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025

Glass Lewis Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting

ISS Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting

Tariff turmoil: What P&G, Pepsi and other companies are saying about tariffs

5 Small Drug Stocks to Buy as Tariff-Related Uncertainty Looms